Search


	Podcast:		In conversation with...
	Episode:		John Collinge on a treatment for CJD
	Category:		Science & Medicine
	Duration:		00:14:45
	Publish Date:		2022-03-16 23:00:00
	Description:		John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.
	Total Play:		0